Home/Filings/4/0001209191-23-049792
4//SEC Filing

Loewen Andrea 4

Accession 0001209191-23-049792

CIK 0001358762other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 5:34 PM ET

Size

5.1 KB

Accession

0001209191-23-049792

Insider Transaction Report

Form 4
Period: 2023-09-14
Loewen Andrea
SVP, Global Regulatory Affairs
Transactions
  • Sale

    Class A common stock

    2023-09-14$172.03/sh3,175$546,18128,416 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $172.02 to $172.035. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

REATA PHARMACEUTICALS INC

CIK 0001358762

Entity typeother

Related Parties

1
  • filerCIK 0001591100

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:34 PM ET
Size
5.1 KB